Drugs / D565
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05207761 | Jan → Oct 2022 | glaucoma | Chong Kun Dang Pharmaceutical | Completed | No outcome recorded |
| Phase 1 | NCT03034486 | Feb → Mar 2017 | — | Chong Kun Dang Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | D565 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03034486 ↗ |